Is MOTS-c + BPC-157 too risky post-lymphoma?

Kyli

Explorer
Joined
Jun 12, 2026
Messages
90
Reaction score
43
Location
Bulgaria
Hi everyone,

Some input from you all would be appreciated. Hodgkin's lymphoma is what my mother had. It began 8-9 years ago and she went through hell - high-dose chemotherapy, radiation, a stem cell transplant, and more. Everything has been fine for 5 years. Lately though she's been feeling weaker, along with GI problems (a chemically damaged esophagus), kidney trouble and high blood pressure.

Since peptides gave me significant results, I suggested she look into some as well. MOTS-c and BPC-157 were on my shortlist for her. Her own research turned up a concern though: both may carry cancer-related risks, as they promote angiogenesis (new blood vessel growth).

Given that cancer history, it's a worry. What do you make of using these peptides in someone with a prior malignancy - any experience or opinions?
 
Back
Top